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Background
It is still controversy in thalassemia major (TM) if Car-
diovascular Magnetic Resonance (CMR) T2* screening
should be initiated before the 10 years. To answer this
question, we studied retrospectively the prevalence of
cardiac iron and function and myocardial fibrosis by
CMR in a consistent cohort of TM patients younger
than 10 years.
Methods
From the 2171 patients enrolled in the MIOT (Myocardial
Iron Overload in Thalassemia) network, we retrospectively
selected the 35 TM patients aged less than 10 years who
had undergone at least one MRI scan. Myocardial iron
overload (MIO) was measured by T2* multislice multiecho
technique. Biventricular function parameters were quanti-
tatively evaluated in a standard way by cine images. To
detect myocardial fibrosis, late gadolinium enhancement
images were acquired.
Results
Patients’ age ranged from 4.2 to 9.7 years. All MRI scans
were performed without sedation. Nine patients (25.7%)
showed no myocardial iron overload (MIO), 22 patients
(62.9%) showed an heterogeneous MIO with a T2* glo-
bal value ≥ 20 ms; 2 patients (5.7%) showed an hetero-
geneous MIO and a T2* global value < 20 ms and 2
patients (5.7%) had a homogeneous MIO (Figure 1).
Biventricular function parameters were assessed only in
28/35 patients (80%), because for 7 patients a short MRI
protocol was chosen to avoid sedation. LV dysfunction
(EF < 54%) was found in one patient (male, 7-year old,
treated with deferoxamine and showing an heteroge-
neous myocardial iron overload with a global T2* value =
31.1 ms). No patient showed RV dysfunction. Finally, 14
patients completed the MRI protocol with acquisition of
the LGE images and none of them showed myocardial
fibrosis. Table 1 reports the data of the 4 patients (3
males and 1 female) with significant myocardial iron
overload (global heart T2* < 20 ms). The youngest
patient was 6 years old, all patient showed no heart dys-
function and in all the iron transfused was less than 35 g.
Conclusions
The first cardiac T2* assessment should be performed as
early as possible without sedation and it is mandatory
whenever poor compliance is suspected or if chelation
has been started late.
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Figure 1 Up: Representative bull’s eye maps identifying the 4 patterns of myocardial iron overload (MIO). The pie chart specifies the
percentage of patients for each pattern. Bottom: Bull’s-eye representation of the 16 myocardial standard segments.
Table 1 Demographic, clinical and MRI data of the 4 patients with global heart T2* < 20 ms.
Parameter Patient 1 Patient 2 Patient 3 Patient 4
Age (yrs) 9.5 6.8 8.8 7.9
Sex M F M M
Transfusions starting age (months) 12 7 12 12
Mean Hb pre-transfusion (g/dl) 9.0 9.7 9.8 9.6
Mean serum ferritin in the previous year (ng/ml) 4500 2488 2579 2359
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Table 1 Demographic, clinical and MRI data of the 4 patients with global heart T2* ?<? 20 ms. (Continued)
Transfused iron (g) 32 14 23 27
Chelation starting age (months) 16 30 24 36
Chelation treatment at the time of MRI Deferoxamine Deferasirox Deferasirox Deferoxamine
Compliance good dubious excellent excellent
Previous chelation therapy None Deferoxamine Deferoxamine -Deferoxamine
-Deferasirox
Global heart T2*/Mid ventricular septum T2* (ms) 11.2/15 13/13 16.2/18 18.9/24.5
MRI CIC (mg/g dry weight) 2.35 1.97 1.51 1.25
N. of pathological segments 16 16 12 9
Pattern of MIO Homogenous Homogenous Heterogeneous Heterogeneous
MRI LIC (mg/g dry weight) 21.4 23.3 9.6 15.1
LV EF (%) 61 NE 63 59
RV EF (%) 63 NE 64 56
M = male, F = female; MRI = Magnetic Resonance Imaging; CIC = cardiac iron concentration; MIO = myocardial iron overload; LIC = liver iron concentration; LV =
left ventricular; EF = ejection fraction; RV = right ventricular; NE = not evaluated.
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